Clinical Trials Directory

Trials / Unknown

UnknownNCT05665777

Chinese Medicine for Treating Chronic Pharyngolaryngitis

The Effectiveness and Safety of Qingyan Lihou Decoction for the Treatment of Chronic Pharyngolaryngitis: A Randomized, Double-blinded, Placebo-controlled Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
74 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine formula in treating Chronic pharyngolaryngitis. Subjects will be randomized into a treatment group or placebo group for 8 weeks, and then followed by an 8-week post-treatment visit.

Detailed description

Chronic pharyngolaryngitis (CP), also known as chronic pharyngitis, is defined as the inflammation of the pharynx, which is at the back of the throat. CP is a common disease characterized by dry throat, sore throat, pharyngeal itching, dry cough, and difficulty in swallowing. In Western medicine, common treatment regimens for CP include lozenges, antibiotics, lasers, and cryotherapy. However, the above treatment modalities may not be effective, and the disease is likely to bounce back repeatedly. Chinese medicine has been used for the treatment of CP for a long time. Many studies have shown that treatment using Chinese herbal medicine is effective in relieving the symptoms of CP. This study is to evaluate the efficacy and safety of oral Qingyan Lihou Decoction in relieving the clinical symptoms of patients with CP.

Conditions

Interventions

TypeNameDescription
DRUGQingyan Lihou DecoctionChinese medicine granules
OTHERPlaceboPlacebo granules

Timeline

Start date
2023-03-30
Primary completion
2025-01-31
Completion
2025-07-31
First posted
2022-12-27
Last updated
2023-07-06

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT05665777. Inclusion in this directory is not an endorsement.